SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Howard Williams who wrote (12756)4/1/2014 10:13:13 AM
From: Mark Buczynski  Read Replies (1) | Respond to of 13111
 
Just curious - Has anyone performed or seen an analysis on the effect that PVCT could have on other sectors of the cancer treatment market? When PV-10 gains approval, I'm wondering what downside effect would be seen in other companies that provide some type of treatment in a more traditional method of cancer remediation? Is there any additional potential incremental market valuation that PVCT could attain?